E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/24/2023 in the Prospect News CLO Daily and Prospect News High Yield Daily.

Solenis term loan frees to trade; Pediatric Associates sets changes; Emerald reveals talk

By Sara Rosenberg

New York, May 24 – Solenis’ incremental term loan B made its way into the secondary market on Wednesday, with levels quoted above its original issue discount.

Solenis’ non-fungible $500 million incremental term loan B (B3/B-) due Nov. 9, 2028 began trading in the afternoon, with levels quoted at 95¼ bid, 96 offered, a market source remarked.

Pricing on the term loan is SOFR plus 500 basis points with a 0.5% floor and it was sold at an original issue discount of 95. The debt has 101 soft call protection for six months.

Meanwhile, in the primary market, Pediatric Associates reduced the size of its incremental first-lien term loan, lifted the spread and widened the original issue discount, and Emerald Expositions (Emerald X Inc.) released price talk on its term loan B in connection with its lender call.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.